Primary Care Use of FRAX®: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men

New Guidelines for the Prevention and Treatment of Osteoporosis

(2011) E Michael Lewiecki et al.   SOUTHERN MEDICAL JOURNAL

FRAX® and its applications to clinical practice

(2009) John A. Kanis et al.   BONE

FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial

(2009) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX Facts

(2009) Nelson B Watts et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Updated fracture incidence rates for the US version of FRAX®

(2009) B. Ettinger et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

(2009) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

Teriparatide in the treatment of osteoporosis

(2008) J. Stroup et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines

(2008) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study

(2008) E. V. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds: the United States perspective

(2008) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

(2008) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis epidemiology update

(2008) Zoe A. Cole et al.   Current Rheumatology Reports